Allogeneic human mesenchymal stem cells (hMSC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic human mesenchymal stem cells (hMSC), covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) [Phase 1]